Nocebo effects in multiple sclerosis trials: A meta-analysis

Multiple Sclerosis

Volumn 16, Issue 7, 2010, Pages 816-828

  Papadopoulos, D ^a   Mitsikostas, D D ^a  

^a ATHENS NAVAL HOSPITAL   (Greece)

Author keywords

meta analysis; meta regression; Multiple sclerosis; nocebo; placebo

Indexed keywords

PLACEBO; IMMUNOLOGIC FACTOR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; HUMAN; MEDLINE; META ANALYSIS; MULTIPLE SCLEROSIS; NOCEBO EFFECT; PALLIATIVE THERAPY; PLACEBO EFFECT; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; ADULT; CHI SQUARE DISTRIBUTION; EVIDENCE BASED MEDICINE; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATIENT DROPOUTS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77955019431     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510370793     Document Type: Article

References (22)

1. Kennedy WP The nocebo reaction. Med Exp Int J Exp Med 1961 ; 95: 203-205.
2. Reeves RR, Ladner ME, Hart RH and Burke RS Nocebo effects with antidepressant clinical drug trial placebos. Gen Hosp Psychiatry 2007 ; 29: 275-277.
3. Preston RA, Materson BJ, Reda DJ and Williams DW Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. Arch Intern Med 2000 ; 160: 1449-1454.
4. Compston A. and Coles A. Multiple sclerosis. Lancet 2008 ; 372: 1502-1517.
5. Treadaway K., Cutter G., Salter A., et al. Factors that influence adherence with disease modifying therapy in MS. J Neurol 2009 ; 256: 568-576.
6. Cunningham A., Gottberg K., von Koch L. and Hillert J. Non-adherence to interferon-beta therapy in Swedish patients with multiple sclerosis. Acta Neurol Scand 2010 ; 121: 154-160.
7. Barsky AJ, Saintfort R., Rogers MP and Borus JF Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002 ; 287: 622-627.
8. DerSimonian R. and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 ; 7: 177-188.
9. Deeks JJ Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. Brit Med J 2001 ; 323: 157-162.
10. Egger M., Davey Smith G., Schneider M. and Minder C. Bias in meta-analysis detected by a simple, graphical test. Brit Med J 1997 ; 315: 629-634.
11. Rosenzweig P., Brohier S. and Zipfel A. The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies. Clin Pharmacol Ther 1993 ; 54: 579-583.
12. Pogge RC The toxic placebo. I. Side and toxic effects reported during the administration of placebo medicine. Med Times 1963 ; 91: 773-778.
13. Robinson DS and Rickels K. Concerns about clinical drug trials. J Clin Psychopharmacol 2000 ; 20: 593-596.
14. Andrykowski MA and Redd WH Longitudinal analysis of the development of anticipatory nausea. J Consult Clin Psychol 1987 ; 55: 36-41.
15. Wolf S. and Pinsky RM Effects of placebo administration and occurrence of toxic reactions. JAMA 1954 ; 155: 339-341.
16. Davis C., Ralevski E., Kennedy SH and Neitzert C. The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. J Clin Psychopharmacol 1995 ; 15: 347-352.
17. Uhlenhuth EH, Alexander PE, Dempsey GM, Jones W., Coleman BS and Swiontek AM Medication side effects in anxious patients: negative placebo responses. J Affect Dis 1998 ; 47: 183-190.
18. Enck P., Benedetti F. and Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008 ; 59: 195-206.
19. Benedetti F., Amanzio M., Vighetti S. and Asteggiano G. The biochemical and neuroendocrine basis of the hyperalgesic nocebo effect. J Neurosci 2006 ; 26: 12014-12022.
20. Beiske AG, Svensson E., Sandanger I., et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008 ; 15: 239-245.
21. Flaten MA, Simonsen T. and Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999 ; 61: 250-255.
22. Benedetti F., Lanotte M., Lopiano L. and Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007 ; 147: 260-271.